The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
02
No.
33
August 13, 1976
- Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group
- In Brief: JNCI Article Describes Advances Pancreatic Cancer; Preventative Oncology Society Formed
- GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants
- Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes
- Obey Aide Objects To Criticism Over Earmarking New NCI Positions
- Cancer Control Planning Conference Delayed To 1977
TCL
Vol.
02
No.
34
August 20, 1976
- NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed
- In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule
- NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough
- Northwestern, Rochester, Howard First In Line For Limited Construction Funds
- Other Institutes Fare Well With ’77 Appropriations
- Centers’ Problems Get Increasing Attention From Staff, Advisors
TCL
Vol.
02
No.
35
August 27, 1976
- NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50
- In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies
- Frederick RFP Available Oct. 22; Three Four May Challenge L-B
- ACCC Manual Tells How To Set Up, Run Cancer Program
- ACCC Recommends Cancer Act Changes
- Abstracts Of Papers Presented By Breast Cancer Task Force
- NCI Advisory Group, Other Cancer Meetings For September, October
- CREG Announced for Premorbid Psychological Factors Study
TCL
Vol.
02
No.
36
September 03, 1976
- FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”
- In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches
- NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee
- Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director
- Nine Cancer Act Changes Considered By NCAB Subcommittee
TCL
Vol.
02
No.
37
September 10, 1976
- FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic
- In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited
- Cancer Control Dilemma: What To do With Successful Demonstrations
- Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment
TCL
Vol.
02
No.
38
September 17, 1976
- New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October
- In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group
- Committee Kills Pay Raise Bill; Rauscher Probably Will Resign
- Conferees Stalled On Money Bill, Running Out Of Time
- NCAB Hung Up On removing $ 45 Million Limit For Core Grants
- Obey Again – Now He’s Blasting NCI For Not Helping NIOSH
- Abstracts Of Papers Presented By Breast Cancer Task Force
TCL
Vol.
02
No.
39
September 24, 1976
- Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director
- In Brief: Money Bill Awaits President’s Decisions; M.D. Anderson To Dedicate New Faculties
- Committee Holds Up RFP For Frederick, Asks Six Month Delay
- Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9
- NCI Advisory Group, Other Cancer Meetings for October, November
- Abstract Of Papers Presented By Breast Cancer Task Force
TCL
Vol.
02
No.
40
October 01, 1976
- Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
- In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
- DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
- Rauscher Disappointed In CREG Progress
- Cancer Commission Surveying for Pill, Hepatoma Association
- President Accepts Rauscher Resignation
- NCI Urged To Back Ultrasounds Studies
- Schmidt Attempted To Answer Critics